New anti-obesity medicines can help stem the rising tide of obesity. But outdated rules make access to these new medicines ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...

Doncaster Council’s new approach aims to alleviate blame from overweight people and respect the “inherent diversity” of body ...

Exchange-traded funds, commonly known as ETFs, are security baskets where a collection of investments is pooled. Like stocks, ...

A new weight loss pill developed by the maker of Ozempic and Wegovy helped overweight and obese people lose up to 13% of ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage ...

The trial included 82 children, of whom 56 got a liraglutide injection once a day. The rest got a placebo ... with the research. Developing anti-obesity medicine for children is complicated ...